Non-invasive Improvement of Buttocks With Magnetic Device

Muscle Tightness Clinical Trial

Official title:

Safety and Patient Satisfaction With Noninvasive Repetitive Pulse Magnetic Stimulation (rPMS) for Aesthetic Improvements of Buttocks

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT03575507
• Other study ID #: BTL-Buttocks_002
• Status: Withdrawn
• Phase: N/A
• Start date: June 1, 2017
• Est. completion date: May 20, 2020

Study information

• Verified date: May 2020
• Source: BTL Industries Ltd.
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will evaluate the clinical safety and patient satisfaction with the high power magnet system for the aesthetic improvement of buttocks. The study is a prospective multi-center open-label single-arm study. The subjects will be enrolled and assigned into a single study group. Subjects will be required to complete four (4) treatment visits and three follow-up visits - 1 month, 3 months and 12 months after the final treatment. Study will be conducted at several study sites.

At the baseline visit, subject's weight will be recorded.

The treatment administration phase will consist of four (4) treatments, delivered twice a week. The applicator will be applied over the gluteal area. Visible contractions will be induced by the device.

At the last therapy visit, the subject's weight will be recorded. In addition, subjects will receive Subject Satisfaction Questionnaire to fill in.

Safety measures will include documentation of adverse events (AE) including subject's experience of pain or discomfort after the procedure. Following each treatment administration and at the follow-up visits, subjects will be checked for immediate post-procedure adverse event assessment.

Post-procedure evaluation (follow-up visits) will be conducted 1 month, 3 months and 12 months after the final treatment. A weight measure will be conducted. Also, subject's satisfaction will be noted.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: May 20, 2020
• Est. primary completion date: September 30, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 22 Years and older

Eligibility

Inclusion Criteria:

• Voluntarily signed informed consent form

• BMI = 30 kg/m2

• Women of child-bearing potential are required to use birth control measures during the whole duration of the study

• Subjects willing and able to abstain from partaking in any treatments other than the study procedure to promote body contouring during study participation

• Subjects willing and able to maintain his/her regular (pre-procedure) diet and exercise regimen without effecting significant change in either direction during study participation

Exclusion Criteria:

• Cardiac pacemakers

• Electronic implants

• Pulmonary insufficiency

• Metal implants

• Drug pumps

• Haemorrhagic conditions

• Anticoagulation therapy

• Heart disorders

• Malignant tumor

• Fever

• Pregnancy

• Breastfeeding

• Following recent surgical procedures when muscle contraction may disrupt the healing process

• Application over menstruating uterus

• Application over areas of the skin which lack normal sensation

• Scars, open lesions and wounds at the treatment area

• Unrepaired abdominal hernia

Related Conditions & MeSH terms

• Muscle Tightness

Intervention

Device:
• Treatment with BTL EMSCULPT device.
The treatment administration phase will consist of four (4) treatments, delivered twice a week. The applicator will be applied over the buttock area. Visible contractions will be induced by the device.

Locations

Country	Name	City	State
Bulgaria	Aesthe Clinic	Sofia
United States	Dr. Mariano Busso Aesthetic Dermatology	Miami	Florida

Sponsors (1)

Lead Sponsor	Collaborator
BTL Industries Ltd.

Countries where clinical trial is conducted

United States,  Bulgaria, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient's satisfaction with study treatment for non-invasive aesthetic improvement of buttocks.	Subject's satisfaction with the therapy results evaluated through the Subject Satisfaction Questionnaire.; The 5-point Likert scale Subject Satisfaction Questionnaire will be used for an analysis of the subject's opinion of the therapy results. Subjects will be evaluating agreement with three different statements (concerning satisfaction with therapy results and appearance of abdominal area after therapy) by choosing an answer on a scale between 1 (Strongly disagree) and 5 (Strongly agree). Minimally 80% of the treated subjects should report the agreement with all three statements given in the questionnaire (answers "Agree" and "Strongly agree") in order to claim subject's satisfaction with the therapy outcome.	18 months
Secondary	Determining side effects and adverse events (AE) associated with the treatment of the gluteal area.	The occurrence of adverse events throughout the whole study.	18 months